Sox-17 activators represent a class of chemical compounds that play a pivotal role in regulating gene expression and cell fate determination. Sox-17, short for SRY (sex-determining region Y)-box 17, is a transcription factor belonging to the Sox family, which is characterized by its high-mobility group (HMG) DNA-binding domain. Sox-17 is specifically involved in the development and maintenance of various tissues and organs during embryogenesis and postnatal life, particularly in the context of endodermal differentiation. Activation of Sox-17 is crucial for orchestrating the genetic program that drives cells towards an endodermal lineage, ultimately leading to the formation of vital structures like the digestive and respiratory systems.
The class of Sox-17 activators includes small molecules and compounds that have been identified for their ability to enhance the expression and activity of Sox-17 in a targeted manner. These activators typically work by binding to specific regulatory regions in the Sox-17 gene or by modulating the activity of upstream signaling pathways that govern Sox-17 expression. Through these mechanisms, Sox-17 activators can influence cellular differentiation, leading to the generation of endodermal cell types. The precise mechanisms of action can vary among different compounds within this class, but they collectively contribute to our understanding of developmental biology and have the ability to impact various research fields, such as stem cell biology and tissue engineering.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wnt Agonist | 853220-52-7 | sc-222416 sc-222416A | 5 mg 25 mg | $157.00 $609.00 | 23 | |
This chemical activates the Wnt/β-catenin signaling pathway, which can influence Sox-17 expression in certain cellular contexts. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3 Inhibitor IX stabilizes β-catenin, indirectly affecting Wnt signaling and possibly Sox-17 activity. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 Inhibitor XVI plays a role in Wnt signaling modulation, potentially influencing Sox-17. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences embryonic development and may affect Sox-17 expression in developmental pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can modulate various signaling pathways including those involving Sox-17. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
This inhibitor of the TGF-β receptor may indirectly affect Sox-17, given TGF-β signaling's role in stem cell regulation. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
IWP-2 inhibits Wnt production, potentially affecting Sox-17 activity through Wnt signaling modulation. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
As an inhibitor of BMP signaling, it might influence Sox-17 activity in developmental pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
This ROCK inhibitor can modulate cytoskeletal dynamics and may indirectly influence Sox-17 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
An inhibitor of the PI3K/AKT pathway, possibly affecting Sox-17 activity in certain cell types. | ||||||